SCHEMBL1614818

SCHEMBL1614818

Cc1nn2c(=O)cc(COC(=O)Cc3ccc(C(F)(F)F)cc3)[nH]c2c1-c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.41
LMNA P02545 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PPARG P37231 3/20 0.39
PPARA Q07869 3/20 0.39
DHFR P00374 2/20 0.38
PLAT P00750 1/20 0.38
KDM4E B2RXH2 2/20 0.37
POLB P06746 2/20 0.37
MAPT P10636 2/20 0.37
CYP1A2 P05177 1/20 0.37
THRB P10828 1/20 0.37
CYP2C9 P11712 1/20 0.37
ALOX15 P16050 1/20 0.37
FPR1 P21462 1/20 0.37
CYP2C19 P33261 1/20 0.37
RECQL P46063 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15926313 0.90 PPARG (0.39) LMNAPPARGPPARADHFRMAPT
SCHEMBL1614661 0.87 LMNA (0.36) LMNANPSR1PPARGPPARAKDM4E
SCHEMBL1614869 0.83 MAPT (0.38) GPR119LMNATDP1NPSR1L3MBTL1
SCHEMBL1614501 0.83 PLAT (0.41) LMNAPLATKDM4EMAPTMEN1
SCHEMBL1613466 0.80 AR (0.40) GPR119PLATMAPTPDE2A
SCHEMBL15926264 0.79 LMNA (0.37) LMNAPPARGPPARAMAPTPDE2A
SCHEMBL15926337 0.79 PLAT (0.47) LMNAL3MBTL1PPARGPLATKDM4E
SCHEMBL15926347 0.77 ARF6 (0.41) LMNANPSR1L3MBTL1PLATKDM4E
SCHEMBL1278731 0.74 PDE2A (0.44) LMNAPOLBPDE2AALDH1A1
SCHEMBL15908924 0.74 ARF6 (0.42) LMNANPSR1L3MBTL1PLATKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796285-B2 Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof HEBEI MEDICAL UNIVERSITY (CN) 2014-08-05 US disclosed
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof PEKING UNIVERSITY (CN) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof KCNJ2, KCNQ5, KCNJ11 GPR119 2319/4885LMNA 2076/4885TDP1 1039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.